Trial Profile
Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment With VerapamilSR/ Trandolapril Fixed Combination (Tarka) in Patients With Essential Hypertension in Routine Clinical Practice.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 May 2012
Price :
$35
*
At a glance
- Drugs Verapamil/trandolapril (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 22 Jun 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
- 22 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 May 2010 New trial record